Updated guidelines for prostate cancer survivorship care published in Journal of Men's Health

Many of the more than 2.5 million men in the U.S. who have received treatment for prostate cancer deal with the often disabling side effects of surgery and radiation and hormonal therapies. To aid in the transition of these patients from specialty to primary care for long-term management of problems such as urinary incontinence and sexual and bowel dysfunction, updated guidelines for prostate cancer survivorship care are published in Journal of Men's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Men's Health website at http://online.liebertpub.com/doi/full/10.1089/jomh.2014.0026 until September 4, 2014.

Ted Skolarus, MD, MPH led a team of authors from University of Michigan, VA Ann Arbor Healthcare System, University of Michigan Comprehensive Cancer Center (Ann Arbor), and Michigan State University (East Lansing) in preparing the article "Recommendations for Prostate Cancer Survivorship Care: An Update to the 2009 Michigan Cancer Consortium Guidelines for the Primary Care Management of Prostate Cancer Post-Treatment Sequelae." Based on information gathered from an expert panel and focus groups, additions to the updated guidelines include patient-reported symptoms assessment, self-management strategies for treatment-related side effects, recommendations for involving partners in survivorship care, and new care coordination strategies.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover key genes linked to DCIS progression